`¿ø¹®`
Á¦¸ñ: Antithrombotic Prophylaxis and Therapy in Renal
Failure...Hartmann B, Czock D, Keller F: Drug therapy in patients with
chronic renal failure. Dtsch Arztebl Int 2xxx; 107(37): 647-56.
-ÀúÀÚ: Kienitz, Carsten; Rosin, Ludger; Paar, W. Dieter
-¼Ò¼Ó±â°ü: Sanofi-Aventis Deutschland GmbH Potsdamer Str. 8 10785 Berlin,
Germany
-¼ö·Ï ÃâÆǹ°: Deutsches Aerzteblatt International (DTSCH AERZTEBL INT),
2/18/2xxx; 108(7): 112-113. (2p)
-ÃâÆǹ° À¯Çü: Journal Article - commentary, letter
-¾ð¾î: English
-ÁÖ¿ä ÁÖÁ¦¸í: Heparin, Low-Molecular-Weight Therapeutic Use
Kidney Failure, Chronic
-ºÎÂ÷ ÁÖÁ¦¸í: Heparin, Low-Molecular-Weight Administration and Dosage;
Thromboembolism Risk Factors
-Àú³Î ÇÏÀ§ÁýÇÕ: Biomedical; Blind Peer Reviewed; Continental Europe;
Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed
The authors postulate a `deep compartment` for enoxaparin. This is
su¡¦(»ý·«)
|